Made available in DSpace on 2016-08-19T18:16:05Z (GMT). No. of bitstreams: 1 Dissertacao Joelma.pdf: 599807 bytes, checksum: 496d32d46e118e53ae391f662bfa6dbd (MD5) Previous issue date: 2012-10-29 / FUNDAÇÃO DE AMPARO À PESQUISA E AO DESENVOLVIMENTO CIENTIFICO E TECNOLÓGICO DO MARANHÃO / The polycystic ovary syndrome (PCOS) is considered the most common endocrine disease during the woman's reproductive life, with prevalence ranging from 5 to 10% of women of reproductive age and is characterized by chronic anovulation and hyperandrogenism, showing complex multifactorial pathogenesis. Objective: To determine the cutoff the lipid accumulation product in women with polycystic ovary syndrome. Methods: Cross-sectional study with 78 women between 18 and 42 years diagnosed with polycystic ovary syndrome according to the Rotterdam criteria directed to nutritional evaluation at the Maternal and Child Unit of the University Hospital UFMA. The interest variables were recorded in protocol form: socio-demographic, behavioral, gynecological history, personal and family history of diseases, anthropometric data (weight, height, body mass index and waist circumference), laboratory tests, imaging exams and blood pressure values. The product of lipid accumulation was calculated by the formula described by Kahn. Regarding the analysis of data normality of quantitative variables was analyzed by the Shapiro Wilk; to compare the means of the variables we used the t Student test. To check the correlation between the lipid product accumulation and cardiovascular risk markers was applied Linear Correlation coefficient (r) test. The lipid product accumulation was analyzed according to the Receiver Operating Characteristic Curve, being discriminated values of high sensitivity and specificity simultaneously. The significance level for all tests was 5%. Results: Using the Receiver Operating Characteristic curve to determine the best cutoff of predicted LAP index risk for cardiovascular disease, it was noted that the value above 39.32 cm.mmol/L representing the area under the 0.8845 of the curve. Every women who had lipid product accumulation product value above the cutoff defined also showed the highest changes in mean of risk markers analyzed of cardiovascular diseases, a statistically significant difference. Regarding the analysis of correlation between the product of lipid accumulation above the cutoff defined and risk markers for cardiovascular diseases, there was a significant correlation. Conclusion: These results demonstrate that cutoff values ≥ 39.32 cm.mmol/L of LAP index seems to indicate the increased risk for CVD and should be used as a screening tool and research for its ease of measurement and interpretation, as well as its low cost and may even have its applicability in primary health care. / A síndrome dos ovários policísticos (SOP) é considerada a endocrinopatia mais comum durante a vida reprodutiva da mulher, com prevalência que varia entre 5 a 10% das mulheres em idade fértil sendo caracterizada por anovulação crônica e hiperandrogenismo, apresentando fisiopatogenia complexa de caráter multifatorial. Objetivo: Determinar o ponto de corte do produto da acumulação lipídica em mulheres com síndrome dos ovários policísticos. Metodologia: Estudo transversal realizado com 78 mulheres entre 18 e 42 anos atendidas no Hospital Universitário Unidade Materno-Infantil da Universidade Federal do Maranhão com o diagnóstico de síndrome dos ovários policísticos de acordo com os critérios de Rotterdam. As variáveis de interesse foram registradas em ficha-protocolo com: dados sócio-demográficos, comportamentais, história ginecológica, antecedentes pessoais e familiares de patologias, dados antropométricos (peso, altura, índice de massa corporal e circunferência da cintura), exames laboratoriais, exame de imagem e valores de pressão arterial. O produto da acumulação lipídica foi calculado pela fórmula descrita por Kahn. Com relação à análise de dados a normalidade das variáveis quantitativas foi analisada pelo teste Shapiro Wilk, para comparação das médias das variáveis utilizou-se o Teste t de Student. Na verificação de Correlação entre o produto da acumulação lipídica e os marcadores de risco cardiovascular foi aplicado o teste de Correlação Linear de Pearson (r). O produto da acumulação lipídica foi submetido à análise segundo a Curva Receiver Operating Characteristic, sendo discriminados os valores de maior sensibilidade e especificidade, simultaneamente. O nível de significância para todos os testes foi de 5%. Resultados: Utilizando-se a Curva Receiver Operating Characteristic para determinar o melhor ponto de corte do produto da acumulação lipídica preditivo de risco para doença cardiovascular, notou-se que o valor acima de 39,32 cm.mmol/L, representou a área sob a curva de 0,8845. Todas as mulheres que apresentaram o valor do produto da acumulação lipídica acima do ponto de corte definido, também apresentaram as maiores alterações nas médias dos marcadores de risco de doença cardiovascular analisados, diferença estatisticamente significativa. No que concerne à análise de correlação entre o produto da acumulação lipídica acima do ponto de corte definido e os marcadores de risco para doenças cardiovasculares, houve uma correlação significativa. Conclusão: Estes resultados demonstram que valores de ponto de corte ≥ 39,32 cm.mmol/L do produto da acumulação lipídica parecem apontar risco aumentado à doença cardiovascular e pode ser utilizado como ferramenta de triagem e investigação pela sua facilidade de mensuração e interpretação, além do baixo custo, podendo ter, inclusive, sua aplicabilidade na atenção primária em saúde.

Os fatores de risco cardiovascular (FRCV) podem estar associados com pior funcionamento cognitivo em idosos e afetar a estrutura cerebral. Usando ressonância magnética (RM) e morfometria baseada em voxel (voxel-based morphometry; VBM), foram avaliados neste estudo volumes regionais de substância branca (SB) cerebral em uma amostra de base populacional de indivíduos saudáveis com idades entre 65-75 anos (n = 156). Usando o escore de risco de Framingham (ERF) como índice de risco cardiovascular, subdividimos a amostra total em três subgrupos de acordo com a gravidade de FRCV. Comparamos os volumes regionais cerebrais de SB entre estes grupos, e investigamos a relação entre volume de SB e desempenho cognitivo. Por fim, dada a possível influência de variações no gene que codifica a apoliproteína E (APOE) sobre cognição, anatomia cerebral e FRCV, avaliamos possíveis mudanças nos resultados das análises volumétricas cerebrais dependendo da presença do alelo APOE?4. No subgrupo de alto risco, detectamos clusteres com volume significativamente menor de SB na região pré-frontal direita dorsolateral juxtacortical em comparação com ambos os subgrupos de baixo e médio risco cardiovascular. Estes achados permaneceram os mesmos quando a análise estatística levou em conta a presença do alelo APOE?4 como covariável de confusão. O desempenho em tarefa cognitiva de controle inibitório foi inversamente correlacionado com o volume de SB pré-frontal direita, em proporção direta com o grau de risco cardiovascular. Redução significativa na SB parietal profunda também foi detectada bilateralmente no subgrupo de alto RCV em comparação com os outros dois subgrupos. Este é o primeiro estudo de VBM usando amostra grande de idosos a documentar a topografia de déficits volumétricos de SB associados com alto ERF em todo o cérebro. A associação significativa entre menor volume de SB e pior desempenho cognitivo em termos de resposta inibitória indica que as mudanças de volume de SB pré-frontal relacionadas com FRCV são clinicamente significativas, uma vez que o controle inibitório é uma operação cognitiva amplamente reconhecida por depender da integridade cortical pré-frontal / Cardiovascular risk factors (CVRF) may be associated with poor cognitive functioning in elderlies and affect brain structure. Using magnetic resonance imaging (MRI) and voxel-based morphometry (VBM), we assessed regional white matter (WM) volumes in a population-based sample of healthy individuals aged 65-75 years (n=156). Using the Framingham Risk Score (FRS) to assess the severity of CVRF, we subdivided the sample in three subgroups. We compared regional WM volumes in the brain between these subgroups, and investigated the relationship between WM volumes and cognitive performance. Also, given the possible influence of variations in the gene that code the apoliprotein E (APOE) on cognition, brain anatomy and CVRF, we evaluate changes in the results of our volumetric analysis depending on the presence of the APOE?4 allele. In the high-risk subgroup, we detected one cluster of significantly reduced WM volume in the right juxtacortical dorsolateral prefrontal region compared to both low- and intermediate-risk subgroups. This finding remained unchanged when the analysis was repeated taking into account the presence of the APOE?4 allele as a confounding covariate. Inhibitory control performance was negatively related to right prefrontal WM volume, in direct proportion to the degree of CVRF. Significantly reduced deep parietal WM was also detected bilaterally in the high-risk CVRF subgroup. This is the first large VBM study documenting the topography of WM volume deficits associated with high FRS across the whole brain. The significant association regarding poor response inhibition indicates that prefrontal WM volume changes related to CVR are clinically meaningful, since inhibitory control is a cognitive operation widely known to rely on prefrontal cortical integrity

INTRODUÇÃO: Ácidos graxos ômega-3 (-3) apresentam características cardioprotetoras e seu baixo consumo tem sido associado ao aumento da resistência insulínica e à baixa concentração de adiponectina no sangue. OBJETIVO: Testar se a suplementação com -3 melhora o perfil cardiometabólico em humanos com fator de risco cardiovascular e se a concentração basal de adiponectina modifica a resposta a essa suplementação. MÉTODOS: Neste ensaio clínico, duplo-cego, placebo-controlado e paralelo, distribuímos aleatoriamente 80 indivíduos nos grupos -3 (suplementado com 3,0 g/dia de óleo de peixe, contendo 37 por cento de ácido eicosapentaenoico [EPA] e 23 por cento de ácido docosahexaenoico [DHA]) e placebo (3,0 g/dia de óleo de girassol, contendo 65 por cento de ácido linoleico), ambos suplementados durante dois meses. Avaliamos concentração sérica de adiponectina e leptina, perfil lipídico e de apolipoproteínas, LDL eletronegativa, marcadores inflamatórios (interleucinas 2, 4, 6, 8 e 10, MCP1, IFN- e TNF-) e metabolismo glicídico (glicose e insulina), adotando nível de significância de 5 por cento . RESULTADOS: No momento basal, os grupos -3 e placebo foram semelhantes quanto ao sexo, idade (média de 52,0 anos), raça, estado civil, trabalho, escolaridade e renda. Após intervenção, o grupo -3 aumentou a concentração sérica de adiponectina. No geral, as citocinas apresentaram redução após intervenção em ambos os grupos; IL-10 foi a única cuja concentração média aumentou, no grupo -3, mas, sem diferença significativa entre os grupos. Ao estratificar os indivíduos do grupo -3 segundo concentração basal de adiponectina, aqueles com menores concentrações tiveram maior redução de colesterol total, LDL, LDL/HDL, LDL/Apo B e LDL(-). Indivíduos que apresentaram maior variação da concentração de adiponectina reduziram a glicemia. CONCLUSÕES: A suplementação com -3 melhora o perfil cardiometabólico e aumenta a concentração sérica de adiponectina em indivíduos com fatores de risco cardiovascular. Indivíduos com baixa concentração basal de adiponectina são mais beneficiados pela ingestão desses ácidos graxos. / BACKGROUND: Omega-3 fatty acids (-3) have shown cardioprotective characteristics and their low consumption has been associated with increased insulin resistance and low blood concentration of adiponectin. OBJECTIVE: To analyze if -3 supplementation improves cardiometabolic profile in humans with cardiovascular risk factor and if adiponectin concentration at baseline level modifies the response to this supplementation. METHODS: In this double-blind, placebo-controlled, clinical trial, we randomized 80 subjects into two groups: -3 (supplemented with 3.0g/day of fish oil containing 37 per cent eicosapentaenoic acid [EPA] and 23 per cent docosahexaenoic acid [DHA]) and placebo (3.0g/day of sunflower oil containing 65 per cent linoleic acid). Both groups received supplementation for two months. At baseline period and after eight weeks of intervention, we evaluated serum adiponectin and leptin, lipid profile and apolipoproteins, electronegative LDL, inflammatory markers (interleukin 2, 4, 6, 8 and 10, MCP1, IFN- and TNF-) and glucose metabolism (glucose and insulin). The significance level was set at p <0.05. RESULTS: At baseline period, -3 and placebo groups were similar regarding sex, age (mean age of 52.0 years), race, marital status, occupation, education and income. After supplementation, -3 group presented an increased serum adiponectin. In general, for both -3 and placebo groups, the concentration of cytokines decreased after intervention IL-10 was the only cytokine that increased the concentration; however, -3 group showed similar variations when compared to the placebo group. After -3 group were stratified by adiponectin concentration at baseline, we observed that individuals with lower adiponectin concentration had a higher reduction of total cholesterol, LDL, LDL/HDL, LDL/Apo B and LDL (-). Individuals who had a higher variation of adiponectin concentration presented reduced blood glucose. CONCLUSIONS: -3 supplementation improves cardiometabolic profile and increases serum adiponectin in people with cardiovascular risk factors. Individuals with low basal concentration of adiponectin are more benefited by the intake of these fatty acids.

Introdução: Pacientes hipertensos resistentes (HR) são indivíduos com pressão arterial não controlada - apesar do tratamento com um diurético e dois anti-hipertensivos com mecanismos de ação diferentes em doses adequadas. Há duas áreas de interesse nesse contexto: a ancestralidade genética que, a princípio, poderia impactar em controles pressóricos, e a farmacometabolômica que, conceitualmente, é um conjunto de mudanças em concentrações de metabólitos - um novo campo que pode esclarecer mecanismos de variações de respostas farmacológicas. Assim, nossos principais objetivos foram: associar mensurações séricas de fármacos anti-hipertensivos e seus metabólitos às respostas farmacoterapêuticas em pacientes hipertensos e analisar a ancestralidade genética em pacientes hipertensos a fim de verificar uma possível associação com as respostas farmacoterapêuticas e a hipertensão resistente. Métodos: Foram utilizadas amostras de 1.597 pacientes, sendo 187 HR. A preparação e a análise da amostra foram realizadas usando uma coluna com nanotubos de carbono de acesso restrito (RACNTs) em um sistema de cromatografia líquida acoplada a espectrômetro de massa (UPLC-MS/MS), em modo column switching. A ancestralidade genética foi realizada usando um painel de 192 marcadores polimórficos; três referências foram usadas (europeia, ameríndia e africana). A raça foi determinada pela autodeclaração, segundo IBGE (branco, pardo, negro e outros). Resultados: O método foi totalmente validado de acordo com as diretrizes da Food and Drug Administration (FDA). O tempo de execução total para cada análise foi de 12,0 min - incluindo a preparação da amostra. Não foram encontradas diferenças significativas nas concentrações de cada analito de acordo com pacientes responsivos e não responsivos, possivelmente, por causa do número de amostra ainda baixo (n total de 171 amostras). As médias das mensurações no grupo dos respondedores foram: clonidina 1,308microg/L; amlodipina 44,044microg/L; enalapril 67,706microg/L; enalaprilato 44,144microg/L; losartana 202,622microg/L; ácido carboxílico de losartana 65,99microg/L, glicuronídeo N-2 de losartana 43,4microg/L e espironolactona 85,87microg/L. Para o grupo dos não respondedores, obtivemos: clonidina 1,4microg/L; amlodipina 78,89microg/L; enalapril 87,821microg/L; enalaprilato 78,878microg/L; losartana 148,026microg/L, ácido carboxílico de losartana 83,535microg/L, glicuronídeo N-2 de losartana 122,452microg/L e espironolactona 79,72microg/L. A raça autodeclarada foi associada aos componentes da ancestralidade genética desses pacientes (p<0,001). A ancestralidade genética, disponível para 1.503 pacientes, teve média geral de 0,53, para europeia; 0,11, para ameríndia; e 0,35, para africana. Não foram encontradas diferenças estatísticas nas médias de ancestralidade de acordo com os grupos respondedor ou HR. Conclusões: O método analítico foi validado e a ancestralidade genética foi realizada, ambos não associados à farmacoterapêutica e à hipertensão resistente / Background: Resistant hypertensive (RH) patients are individuals with uncontrolled blood pressure - despite treatment with one diuretic and two antihypertensives with different mechanisms of action in adequate doses. There are two areas of interest in this context: genetic ancestry that could initially impact on blood pressure controls, and pharmacometabolomics, which conceptually is a set of changes in metabolite concentrations - a new field that can clarify mechanisms of pharmacological response variation. Thus, our main objectives were: to associate serum measurements of antihypertensive drugs and their metabolites to the pharmacotherapeutic responses in hypertensive patients and to analyze genetic ancestry in hypertensive patients in order to verify a possible association with pharmacotherapeutic responses and resistant hypertension. Methods: Samples of 1,597 patients were used, being 187 RH. Sample preparation and analysis were performed using a column with restricted access carbon nanotubes (RACNTs) in a liquid chromatography coupled to mass spectrometer (UPLC-MS/MS) in column switching mode. Genetic ancestry was performed using a panel of 192 polymorphic markers; three references were used (European, Amerindian and African). The race was determined by self-declaration, according to IBGE (white, brown, black and others). Results: The method has been fully validated according to the guidelines of the Food and Drug Administration (FDA). The total run time for each analysis was 12.0 min including sample preparation. No significant differences were found in the concentrations of each analyte according to responsive and nonresponsive patients, possibly because of the still low number of samples (total n of 171 samples). The means of the measurements in the responders group were: clonidine 1.308microg/L; amlodipine 44.044microg/L; enalapril 67.706microg/L; enalaprilat 44.144microg/L; losartan 202.622microg/L; losartan carboxylic acid 65.99microg/L, N-2 glucuronide of losartan 43,4microg/L and spironolactone 85.87microg/L. For the group of non-responders, we obtained: clonidine 1.4 microg/L; amlodipine 78.89microg/L; enalapril 87.821microg/L; enalaprilat 78.878microg/L; losartana 148.026microg/L, losartan carboxylic acid 83.535microg/L, N-2 glucanide of losartan 122.452microg/L and spironolactone 79.72microg/L. Self-reported race was associated with the components of the genetic ancestry of these patients (p<0.001). Genetic ancestry, available for 1,503 patients, had an overall mean of 0.53 for European; 0.11 for Amerindian; and 0.35 for African. No statistical differences were found in the means of ancestry according to responder or RH groups. Conclusion: The analytical method was validated and genetic ancestry was performed, both unrelated to pharmacotherapeutic and resistant hypertension

<p>Uvod. Kardiovaskularne bolesti kao deo grupe hroničnih nezaraznih bolesti predstavljale su i predstavljaju vodeći uzrok obolevanja i umiranja u svetu. Brojni naučni dokazi potvrđuju da je arterijska hipertenzija glavni kardiovaskularni faktor rizika, a da postignute vrednosti krvnog pritiska niže od 140/90mmHg značajno smanjuju kardiovaskularni rizik, odnosno pojavu kardiovaskularnih događaja, prvenstveno infarkta miokarda i moždanog udara. Arterijska hipertenzija je najzastupljenije stanje koje se viđa u ustanovama primarne zdravstvene za&scaron;tite, a mere prevencije, rano dijagnostikovanje, lečenje i kontrola arterijske hipertenzije predstavljaju javno-zdravstveni izazov u svim zemljama sveta. Ciljevi. Ciljevi istraživanja su utvrđivanje prevalencije arterijske hipertenzije koja je pod kontrolom; utvrđivanje prevalencije i povezanosti metaboličkih faktora sa ishodom u kontroli krvnog pritiska; utvrđivanje prevalencije i povezanosti nezdravih stilova života sa ishodom u kontroli krvnog pritiska; utvrđivanje prediktora lo&scaron;e kontrole krvnog pritiska i izračunavanje 10-godi&scaron;enjeg kardivaskularnog rizika. Metode. U studiju preseka (prevalencije) uključeno je 373 ispitanika oba pola starosti od 45 do 75 godina sa dijagnozom arterijske hipertenzije u kartonu koji su u periodu od oktobra 2015. godine do februara 2016. godine dolazili kod svog izabranog lekara. Prikupljanje podataka obavljeno je merenjem krvnog pritiska, antropometrijskim merenjima, biohemijskim analizama i anketiranjem popunjavanjem upitnika. Rezultati. Uzorak ispitanika je činilo 55% žena i 45% mu&scaron;karaca prosečne starosti 59&plusmn;6,3 godine. Utvrđena je niska učestalost arterijske hipertenzije pod kontrolom od 39,1%, a visoka učestalost metaboličkih faktora (44,5% predgojaznosti, 34% gojaznosti, 29% &scaron;ećerne bolesti, 88,2% povi&scaron;enih masnoća i 41,8% metaboličkog sindroma) kao i njihova povezanost sa ishodom u kontroli krvnog pritiska jer su ispitanici sa nekontrolisanim krvnim pritiskom najče&scaron;će imali dva faktora rizika (40,5%), dok su ispitanici sa kontrolisanim krvnim pritiskom najče&scaron;će imali jedan faktor rizika (45,9%). Utvrđeno je da su prosečne vrednosti sistolnog, dijastolnog pritiska i pulsa bile značajno (p&lt;0,001) niže u grupi sa kontrolisanim pritiskom kao i da su ispitanici sa nekontrolisanim pritiskom imali značajno veći obim struka (p=0,006), metabolički sindrom (p&lt;0,001) i značajno če&scaron;će pili veći broj lekova (p&lt;0,001). Utvrđena je visoka učestalost pu&scaron;enja (26,3%) i visoka učestalost sedentarnog načina života (76,7%) kao i da znanja, stavovi i pona&scaron;anja ispitanika u vezi faktora rizika (pu&scaron;enja, konzumiranja alkohola, fizičke neaktvnosti i prekomerne upotrebe soli) nisu na zadovoljavajućem nivou. Kao nezavisni prediktori arterijske hipertenzije koja nije pod kontrolom dobijeni su obim struka, telesna masa, indeks telesne mase, starost, vrednost pulsa, broj lekova koje ispitanici piju, pasivno pu&scaron;enje, nesvesnost o postojanju arterijske hipertenzije, neznanje o &scaron;tetnosti konzumiranja prekomerne količine alkohola, nepreležan infarkt miokarda i moždani udar. Izračunato je da je u visokom i veoma visokom riziku od neželjenih kardiovaskularnih događaja u desetogodi&scaron;njem periodu 2,7% ispitanika sa arterijskom hipertenzijom bez dijabetesa i 22,2% hipertenzivnih ispitanika sa dijabetesom. Zaključak. Potrebno je sprovođenje javno-zdravstveno vaspitnih i promotivnih aktivnosti u cilju povećanja znanja, promene stavova i pona&scaron;anja kod populacije sa arterijskom hipertenzijom usled lo&scaron;e kontrole krvnog pritiska i prisustva visoke učestalosti pridruženih faktora rizika koji utiču na njegovu kontrolu.</p> / <p>Introduction. Cardiovascular diseases, as part of a group of chronic noncommunicable diseases, have been and still are the leading cause of morbidity and mortality in the world. Numerous scientific proofs confirm that arterial hypertension is a major cardiovascular risk factor and that the achieved blood pressure values lower than 140/90mmHg significantly reduce cardio-vascular risk, or the appearance of cardio-vascular events, mainly myocardial infarction and stroke. Arterial hypertension is the most common condition that is seen in primary health care institutions and preventive measures, early diagnosis, treatment and control of arterial hypertension are a public health challenge in all countries of the world. Objectives. The objectives of the research were to determine the prevalence of arterial hypertension which is controlled; to determine the prevalence and correlation of the metabolic factors with the outcome in blood pressure control; to determine the prevalence and correlation of unhealthy lifestyles with the outcome in blood pressure control; to determine the predictors of poor blood pressure control and calculate a 10-year cardiovascular risk. Methods. The cross-sectional study (of prevalence) included 373 respondents of both sexes aged 45 to 75 years diagnosed with arterial hypertension who in the period from October 2015 to February 2016 visited their chosen doctor. Data collection was performed by measuring blood pressure, anthropometric measurements, biochemical analyses and surveying by filling out a questionnaire. Results. The sample consisted of 55% women and 45% men, of mean age of 59&plusmn;6.3 years. The results showed low incidence of arterial hypertension under control of 39.1%, and high incidence of metabolic factors (44.5% of overweight, 34% of obesity, 29% of diabetes mellitus, 88.2% of elevated fat and 41.8% of the metabolic syndrome) as well as their association with the outcome in blood pressure control as the respondents with uncontrolled blood pressure usually had two risk factors (40.5%), while the group with controlled blood pressure usually had one risk factor (45.9%). It was found that the average values of systolic, diastolic blood pressure and heart rate were significantly (p&lt;0.001) lower in the group with controlled blood pressure, as well as that the respondents with uncontrolled pressure had a significantly greater waist circumference (p=0.006), the metabolic syndrome (p&lt;0.001) and more often drunk greater number of medicines (p&lt;0.001). There was a high prevalence of smoking (26.3%) and a high incidence of sedentary lifestyle (76.7%) and it was found that knowledge, attitudes, and behaviors of the respondents related to risk factors (smoking, alcohol consumption, physical inactivity and excessive use of salt) were not satisfactory. As independent predictors of arterial hypertension which was not under the control, the study obtained waist circumference, body weight, body mass index, age, heart rate value, the number of medicines that the respondents drunk, second-hand smoking, unawareness of the existence of arterial hypertension, inexperience on the harmful effects of excessive amounts of alcohol, not overcome myocardial infarction and stroke. It was calculated that 22.2% of hypertensive respondents with diabetes and 2.7% of respondents with arterial hypertension without diabetes were in the high and very high risk of adverse&nbsp; Conclusion. It is necessary to implement public-health educational and promotional activities in order to increase the knowledge, changes in the attitudes and behavior of the population with arterial hypertension due to the poor control of blood pressure and the presence of the high incidence of associated risk factors affecting its control.</p>

<p>Uvod: Kardiovaskularne bolesti predstavljaju vodeći uzrok obolevanja i umiranja savremenog čoveka i vodeći su javno-zdravstveni problem u svetu i kod nas. Brojna istraživanja sugeri&scaron;u da se mediteranski način ishrane povezuje sa smanjenjem rizika za nastanak i razvoj kardiovaskularnih bolesti i drugih masovnih nezaraznih bolesti kao i smanjenjem stope ukupnog mortaliteta. Cilj istraživanja: Utvrditi stepen pridržavanja mediteranskom načinu ishrane kod obolelih od akutnog koronarnog sindroma i kod osoba sa utvrđenim rizikom za nastanak kardiovaskularnih bolesti, upotrebom validovanog skora mediteranske ishrane &ndash; MedDiet skora. Takođe, cilj istraživanja je bio da se utvrdi da li postoji značajna razlika u vrednostima biohemijskih i kliničkih faktora rizika za razvoj kardiovaskularnih bolesti između dve posmatrane grupe ispitanika, kao i da se odredi granična vrednost MedDiet skora između poželjnog i rizičnog načina ishrane za nastanak akutnog koronarnog sindroma. Metod: Istraživanje je sprovedeno kao analitička studija preseka na uzorku od 294 ispitanika (146 žena i 148 mu&scaron;karaca), starosti od 30 do 82 godine. Istraživanje je sprovedeno u vremenskom periodu od 07.02.2016. godine do 16.03.2017. godine. Prvu grupu činili su ispitanici kod kojih je&nbsp; dijagnostikovan akutni koronarni sindrom, koji su hospitalizovani u Institutu za kardiovaskularne bolesti Vojvodine u Sremskoj Kamenici, dok su drugu grupu činili ispitanici kod kojih je utvrđeno prisustvo najmanje jednog faktora rizika za nastanak kardiovaskularnih bolesti, bez klinički manifestne koronarne bolesti, koji su se javili na pregled u Savetovali&scaron;te za pravilnu ishranu, Instituta za javno zdravlje Vojvodine u Novom Sadu. Kod svih učesnika u studiji izvr&scaron;ena su: antropometrijska merenja, merenje arterijskog krvnog pritiska, odgovarajuće biohemijske analize, EKG i anketiranje upotrebom posebno pripremljenog upitnika, u čijem sastavu se nalazio i MedDiet skor &ndash; validovan skor system za procenu stepena zastupljenosti mediteranskog načina ishrane kod pojedinca. Rezultati istraživanja: Srednja vrednost MedDiet skora ispitanika bez akutnog koronarnog sindroma bila je 27,48&plusmn;6,59, dok je srednja vrednost MedDiet skora ispitanika sa akutnim koronarnim sindromom bila 20,53&plusmn;4,01. Razlika srednjih vrednosti MedDiet skora između dve grupe ispitanika bila je statistički značajna (p=0,029). Ispitivanjem prediktivnih vrednosti pojedinih varijabli utvrđeno je da su MedDiet skor i glikemija na&scaron;te odlični markeri za akutni koronarni sindrom (AUROC=0,815, p&lt;0,0005 i AUROC=0,829, p&lt;0,0005, respektivno). Rezultati istraživanja su pokazali da konzumiranje pojedinih namirnica iz kategorija definisanih MedDiet skorom (voće, povrće, živinsko meso i maslinovo ulje) može doprineti smanjenju rizika za nastanak akutnog koronarnog sindroma. Konzumiranje crvenog mesa i mesnih prerađevina povećava rizik od pojave akutnog koronarnog sindroma. Utvrđena granična vrednost MedDiet skora iznosila je 22,5. Vrednosti MedDiet skora &le;22,5 predstavljaju faktor rizika za nastanak akutnog koronarnog sindroma, dok vrednosti MedDiet skora &gt;22,5 ukazuju na smanjen rizik za nastanak akutnog koronarnog sindroma. Multivarijantnom regresionom analizom pokazano je da na pojavu akutnog koronarnog sindroma utiču sledeći faktori rizika: godine starosti 1,063 (1,270-1,819), mu&scaron;ki pol 4,071 (1,901-8,719), pu&scaron;enje 3,067 (1,322-7,114), indeks telesne mase 0,902 (0,839-0,970), sistolni pritisak 1,020 (1,003-1,037), glikemija na&scaron;te 1,520 (1,025-1,101) i MedDiet skor 0,783 (0,722-0,849). Zaključak: Akutni koronarni sindrom predstavlja značajan javno-zdravstveni problem odraslog stanovni&scaron;tva u Republici Srbiji na &scaron;ta ukazuju visoke prevalencije u populaciji. Rezultati sprovedenog istraživanja pokazuju da je i diskretnim povećanjem unosa namirnica koje predstavljaju osnovu mediteranskog načina ishrane moguće postići značajne zdravstvene koristi. Ovi rezultati mogu predstavljati okvir za razvoj lokalnog skoring sistema ishrane prikladnog za nemediteransko područje, kao i modela za procenu rizika za nastanak akutnog koronarnog sindroma u na&scaron;oj populaciji.</p> / <p>Introduction: Cardiovascular diseases are the leading cause of morbidity and mortality of a modern society and are major public health problem in our country and also worldwide. Numerous studies suggest that the Mediterranean diet is associated with a reduction in the risk of developing cardiovascular diseases and other non-communicable diseases, as well as reduction in the overall mortality rate. Aim: To determine the degree of Mediterranean diet complience in subjects with acute coronary syndrome and subjects with an established risk for developing cardiovascular diseases, using validated Mediterranean diet score - MedDiet. Also, the aim of the study was to determine whether there is a significant difference in the values of the&nbsp; biochemical and clinical risk factors for the development of cardiovascular diseases between the two observed groups of subjects, and to determine the cut-off value of the MedDiet score between the favorable and unfavorable dietaty pattern for the development of acute coronary&nbsp; syndrome. Method: The study was conducted as an analytical cross-sectional study with enrollment of 294 subjects (146 women and 148 men), 30 to 82 years of age. The research was conducted during the period from 02/07/2016 until 03/16/2017. The first group of subjects consisted of patients diagnosed with acute coronary syndrome who were hospitalized at the Institute for Cardiovascular Diseases Vojvodina in Sremska Kamenica. The second group was comprised of subjects with established at least one major risk factor for the development of cardiovascular diseases but without clinically manifest coronary artery disease, who came to the medical examination of the Counseling Center for Proper Nutrition, Institute of Public Health of Vojvodina in Novi Sad. Among all participants in the study the following examinations were conducted: anthropometric measurements, arterial blood pressure measurements, appropriate biochemical analysis, ECG and surveys using a specially prepared questionnaire, which included MedDiet score - validated score system for assessing the degree of compliance with Mediterranean dietary pattern among subjects. Results of the study: The average value of the MedDiet score among subjects without acute coronary syndrome was 27.48 &plusmn; 6.59, while the average value of MedDiet score among subjects with acute coronary syndrome was 20.53 &plusmn; 4.01. The difference in MedDiet average values between the two groups of subjects was statistically significant (p = 0.029). By examining the predictive values of individual variables, it was shown that MedDiet score and fasting blood sugar were excellent markers for acute coronary syndrome (AUROC = 0.815, p&lt;0.0005 and AUROC = 0.829, p &lt;0.0005, respectively). The results of the study showed that the consumption of certain foods in the categories defined by MedDiet score (fruits, vegetables, poultry, and olive oil) can contribute to reduction of the risk for developing acute coronary syndrome. On the other hand, consuming red meat and meat products increased the risk of acute coronary syndrome. The established cut-off value for MedDiet score was 22.5. MedDiet score &le;22.5 practicaly indicated greater risk for the development of acute coronary syndrome, while MedDiet score&gt; 22.5 indicated reduced risk for the development of acute coronary syndrome. Multivariate regression analysis showed that acute coronary syndrome is affected by the following risk factors: age 1,063 (1,270-1,819), male gender 4,071 (1,901-8,719), smoking 3,067 (1,322-7,114), body mass index 0,902 (0.839-0.970 ), systolic blood pressure 1.020 (1.003-1.037), fasting blood sugar 1.520 (1.025-1.101) and MedDiet score 0.783 (0.722- 0.849). Conclusion: Acute coronary syndrome is a major public health problem in the adult population of the Republic of Serbia, as indicated by its high prevalence. The results of the conducted research show that discrete increase in food intakes of foods which represent the basis of the Mediterranean diet, can lead to significant health benefits. These results can represent a framework for the development of a local scoring system for a non-mediterranean area, and also for creation of risk assessment model for acute coronary syndrome in our population.</p>

Although the clinical efficacy of statins has been well established, there is a wide inter-individual variation in the lipid responses to statins. Pharmacogenetic studies have identified some genetic differences that contribute to the variation, but overall the results have been disappointing. The studies described in this thesis were performed to examine whether certain genetic variants predicted the lipid responses to rosuvastatin in Chinese patients. Over 400 Chinese patients with increased risk of cardiovascular disease (CVD) who were treated with rosuvastatin 10 mg daily for at least 4 weeks (more than 97% of patients had at least 6 weeks treatment) were studied, including 166 having familial hypercholesterolaemia (FH) and 36 having rheumatoid arthritis (RA). They were genotyped for 135 polymorphisms in 62 candidate genes/loci potentially related to pharmacokinetics or pharmacodynamics of statins and lipid metabolism. Associations between genetic polymorphisms and the lipid responses to rosuvastatin were analyzed in 386 patients with good compliance. The associations between genetic polymorphisms and some risk factors for CVD including baseline lipid levels, high-sensitivity C-reactive protein (hsCRP), uric acid and bilirubin levels were also analyzed. / Some novel genetic determinants of the LDL-C response to rosuvastatin treatment have been identified in this study. The responses in HDL-C and triglycerides were related more closely to the baseline levels of these lipids than to any of the polymorphisms examined. Genetic associations with baseline lipid parameters, hsCRP, uric acid and bilirubin were identified and generally correspond with some of the previous reports of studies in Chinese and other ethnic groups. / The key findings of the study are as follows: 1. The polymorphisms most highly associated with the low-density lipoprotein cholesterol (LDL-C) response were 421C>A in the ATP-binding cassette G2 (ABCG2) gene (P=9.2x10 -7), followed by 18281G>A (V257M) in the flavin-containing monooxygenase 3 (FMO3) gene (P=0.0002), 1421C>G in the lipoprotein lipase (LPL) gene (P=0.002), and rs4420638 in the apolipoprotein E/C-I/C-IV/C-II (APOE/C1/C4/C2) gene cluster (P=0.004). These genetic polymorphisms and having FH totally explained 13.6% of the variance in percentage change in LDL-C in response to rosuvastatin. The greater percentage reduction in LDL-C in patients with the ABCG2 421AA genotype compared to those with the ABCG2 421CC genotype was equivalent to at least doubling the dose of rosuvastatin. 2. Three SNPs (glucokinase regulator [ GCKR] rs1260326, apolipoprotein AS [APOA5] -1131T>C and the solute carrier organic anion transporter 1B1 [SLCO1B1] 521T>C) tended to be associated with percentage changes in high-density lipoprotein cholesterol (HDL-C) (P&lt;0.05), but none of these reached the overall significance level. In multivariate stepwise regression analysis, baseline HDL-C (P=1.6x10 -6), having diabetes (P=0.0004) or RA (P=0.002) and the SLCO1B1 521T>C polymorphism (P=0.03) were determinants of HDL-C responses, contributing 9.9% of the variance in percentage change in HDL-C, but the genetic factors only contributed to 0.8% of the variance. 3. The triglyceride response to rosuvastatin was highly variable and was strongly related to baseline levels. The diacylglycerol acyltransferase-2 (DGAT2) rs10899113 C>T polymorphism tended to be associated with reduced triglyceride response in a gene-dose dependent manner. However, in multivariate stepwise regression analysis, baseline triglyceride level was the only factor that strongly related to the triglyceride response, explaining 14.4% of the variance. 4. This study has also analyzed relationships between on-treatment plasma hsCRP concentrations and cardiovascular risk factors and 14 single nucleotide polymorphisms in CRP and other candidate genes, which showed that central obesity, low HDL-C and CRP polymorphisms are major determinants of higher hsCRP levels in Chinese patients on treatment with rosuvastatin. 5. The association between genetic polymorphisms and lipid traits were analyzed in FH and non-FH patients separately due to their different lipid profiles. The analysis has shown that there were different genetic predictors of lipid levels in patients with and without FH and that more genetic factors appeared to affect the baseline lipid levels in patients with FH compared to non-FH patients, suggesting complex interactions between genetic and environmental factors and plasma cholesterol levels in patients with and without FH. 6. The SLC2A9 (solute carrier family 2, member 9) rs1014290 T>C was significantly associated with plasma uric acid levels in a gene-dose dependent manner (P=1.0x10-5) and the relationship was more pronounced in women or in patients without hypertension than in men or patients with hypertension. The ABCG2 421 C>A did not show a significant effect on uric acid levels. 7. The UGT1A1 (uridine diphosphate glucuronosyltransferases family, polypeptide A1) variants *28 (P=1.5x10 -9) and *6 (P=2.2x10-7) were independently associated with increased baseline bilirubin levels. Polymorphisms in SLCO1B1 did not appear to affect bilirubin levels in this study. / Hu, Miao. / Adviser: Brian Tomlinson. / Source: Dissertation Abstracts International, Volume: 72-04, Section: B, page: . / Thesis (Ph.D.)--Chinese University of Hong Kong, 2010. / Includes bibliographical references (leaves 230-264). / Electronic reproduction. Hong Kong : Chinese University of Hong Kong, [2012] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Electronic reproduction. Ann Arbor, MI : ProQuest Information and Learning Company, [200-] System requirements: Adobe Acrobat Reader. Available via World Wide Web. / Abstract also in Chinese.

Xiao, Kang. / Thesis (M.Phil.)--Chinese University of Hong Kong, 2011. / Includes bibliographical references (leaves 83-103). / Abstracts in English and Chinese. / Abstract --- p.I / 摘要 --- p.VI / Chapter Chapter 1 --- Background --- p.1 / Chapter 1.1 --- Introduction --- p.1 / Chapter 1.2 --- Albuminuria --- p.3 / Chapter 1.2.1 --- Definition --- p.3 / Chapter 1.2.2 --- Albuminuria in adolescents/children --- p.6 / Chapter 1.2.3 --- Prevalence of albuminuria in adults and adolescents --- p.8 / Chapter 1.2.4 --- Pathogenesis of albuminuria --- p.10 / Chapter 1.3 --- CVD and risk factors --- p.12 / Chapter 1.4 --- The associations between microalbuminuria and CVD risk factors --- p.17 / Chapter 1.5 --- Heavy metals --- p.18 / Chapter 1.5.1 --- Definition of heavy metals --- p.18 / Chapter 1.5.2 --- Adverse effects of heavy metals --- p.19 / Chapter 1.5.3 --- Heavy metals exposure In Hong Kong population: the local scene --- p.28 / Chapter 1.6 --- MicroRNAs --- p.29 / Chapter 1.6.1 --- The discovery of microRNAs --- p.29 / Chapter 1.6.2 --- The biogenesis of microRNAs --- p.30 / Chapter 1.6.3 --- The function of microRNAs --- p.31 / Chapter 1.7 --- Hypothesis --- p.40 / Chapter Chapter 2 --- Methodology --- p.41 / Chapter 2.1 --- Population --- p.41 / Chapter 2.2 --- Laboratory assays --- p.42 / Chapter 2.3 --- Statistical analysis --- p.44 / Chapter Chapter 3 --- Results --- p.46 / Chapter 3.1 --- Demographic and baseline clinical data --- p.46 / Chapter 3.2 --- Microalbuminuria and cardiovascular risk factors --- p.48 / Chapter 3.3 --- Microalbuminuria and heavy metals --- p.51 / Chapter 3.4 --- Microalbuminuria and miRNAs --- p.54 / Chapter 3.5 --- "Microalbuminuria, miRNAs, heavy metals and cardiovascular risk factors" --- p.57 / Chapter 3.6 --- miRNAs and heavy metals --- p.60 / Chapter Chapter 4 --- Discussion --- p.62 / Chapter 4.1 --- Heavy metals and microalbuminuria --- p.62 / Chapter 4.2 --- Heavy metals and CVD risk factors --- p.68 / Chapter 4.3 --- Microalbuminuria and CVD risk factors --- p.75 / Chapter 4.4 --- miRNAs and Heavy metals --- p.76 / Chapter 4.5 --- miRNAs and microalbuminuria --- p.77 / Chapter 4.6 --- Conclusion --- p.79 / Acknowledgement --- p.82 / References --- p.83

Objetivo: A doença cardiovascular é umas das principais causas de mortalidade tardia não relacionada ao fígado após o transplante hepático. O objetivo deste estudo foi avaliar os efeitos a longo prazo do transplante hepático sobre o perfil metabólico e o sistema cardiovascular. Métodos: Trinta e seis receptores de fígado foram avaliados um ano após o transplante hepático para avaliar a prevalência da síndrome metabólica e outros preditores de doenças cardiovasculares. Foram coletados dados antropométricos, exames bioquímicos, biomarcadores de aterosclerose e calculado o escore de Framingham. Quatro anos após o transplante, essa avaliação foi repetida e todos os participantes foram submetidos a uma tomografia de coronárias para obtenção do escore de cálcio coronariano. Os dados obtidos foram comparados para estimar a progressão do risco cardiovascular. Resultados: A população era constituída na sua maioria por indivíduos do sexo masculino, de cor branca e transplantados por hepatite C. Observou-se um aumento estatisticamente significativo na circunferência abdominal e na prevalência de dislipidemia, obesidade e síndrome metabólica ao longo do tempo. Todos os biomarcadores de aterosclerose estudados apresentaram aumento importante dos seus níveis no quarto ano (p < 0,001) após o transplante. Quanto ao escore de cálcio, 25% dos pacientes apresentaram calcificação coronariana moderada a grave, conferindo maior risco de evento cardíaco. A mediana do escore de Framingham aumentou substancialmente do primeiro ao quarto ano (p=0,022), alterando a estratificação de baixo para alto risco. Isso se refletiu em um aumento significativo de eventos cardiovasculares após quatro anos de transplante hepático. Conclusões: A prevalência de síndrome metabólica e risco cardiovascular aumenta significativamente do primeiro ao quarto ano após transplante hepático. O escore de cálcio coronariano e os biomarcadores de aterosclerose podem melhorar a estratificação de risco e ajudar a prevenir a progressão de doenças cardiovasculares / Objective: Cardiovascular diseases are a major non-liver-related contributor to late mortality after liver transplantation. The aim of this study was to assess the long-term effects of liver transplantation on the metabolism and cardiovascular system. Methods: Thirty-six liver recipients were assessed one year after transplantation to evaluate the prevalence of metabolic syndrome and other predictors of cardiovascular diseases. The data collected included anthropometric features, biochemical test results, Framingham risk score and atherosclerosis biomarkers. This evaluation was repeated four years after transplantation, and a coronary artery calcium score was obtained from all participants. Data were compared to estimate cardiovascular risk progression. Results: The population consisted mostly of white male subjects who underwent transplantation for hepatitis C. Significant increases were observed in waist circumference and the prevalence of dyslipidemia, obesity and metabolic syndrome over time. All biomarkers of atherosclerosis studied showed increased levels at the fourth year (p < 0.001). Regarding the calcium score, 25% of patients had moderate to severe coronary artery calcification, conferring an enhanced risk of a cardiac event. The median Framingham risk score substantially increased from the first to fourth year (p=0.022), changing the stratification from low to high risk. This change was reflected in a significant increment of cardiovascular events four years after liver transplantation. Conclusions: The prevalence of metabolic syndrome and cardiovascular risk significantly increased from the first to fourth year after liver transplantation. Coronary artery calcium scores and atherosclerosis biomarkers may improve risk stratification and help prevent symptomatic cardiovascular disease

Submitted by Rosina Valeria Lanzellotti Mattiussi Teixeira (rosina.teixeira@unisantos.br) on 2017-04-10T12:24:50Z No. of bitstreams: 1 Yuri C. Pereira Bezerra.pdf: 1511197 bytes, checksum: 07b7896685114a1850da4781cd9b97e8 (MD5) / Made available in DSpace on 2017-04-10T12:24:50Z (GMT). No. of bitstreams: 1 Yuri C. Pereira Bezerra.pdf: 1511197 bytes, checksum: 07b7896685114a1850da4781cd9b97e8 (MD5) Previous issue date: 2017-01-30 / This observational, ecological time series study aims to verify the relationship between adult hospitalizations for total cardiovascular diseases (CVDD) and air pollution stratified by sex in residents of the city of São Paulo from 2000 to 2013, observing their Structure of lag. Analyzes were stratified by age group and sex and included hospitalizations for Total Cardiovascular Diseases (ICD10: Chapter IX - I00-I99). The pollutant and meteorological data were provided by the Environmental Sanitation Technology Company of the State of São Paulo. The relationship between air pollutants and climatic factors in hospitalizations for Total Cardiovascular Diseases was analyzed by means of a polynomial distribution lag model for both temperature and air pollutants with a lag structure of up to 6 days after exhibition. Generalized linear models of Poisson regression were used, controlling for long-term seasonality, days of the week, and holidays. The following was calculated the increase in the number of hospitalizations for the interquartile difference of the pollutants significant in the regression model, as well as for the meteorological factors. For all hospital admissions for Total Cardiovascular Diseases, acute short-term effects were observed. The O3 was the only pollutant that did not have any relation to any of the analyzed results and NO2 had the greater effect, for an increase of interquartile 50.22 ¿g / m 3 of NO2, an increase of 13.09% (IC95 %: 4.74% - 21.45%), among the total admissions from 30 to 44 years. Stratifying the analysis by age group, a greater effect was found for hospitalizations from 45 to 60 years. Regarding gender, between the age group 30 and 44, the men stood out, and for the 45-60 age group, the women were more affected than the men. / Este estudo observacional, ecológico de series temporais tem por objetivo de verificar a relação entre internações de adultos por doenças cardiovasculares totais (DCVT) e poluição do ar estratificado por sexo, em residentes do município de São Paulo no período de 2000 a 2013, observando sua estrutura de defasagem. As analises foram estratificadas por faixa etária e sexo e incluíram internações por Doenças Cardiovasculares Totais (CID10: capítulo IX - I00-I99). Os dados de poluentes e meteorológicos foram fornecidos pela Companhia de Tecnologia de Saneamento Ambiental do Estado de São Paulo. A relação entre poluentes do ar e fatores climáticos nas internações por Doenças Cardiovasculares Totais, foram analisadas por meio de um modelo de defasagem de distribuição polinomial tanto para a temperatura como para os poluentes do ar, com uma estrutura de defasagem de até 6 dias após a exposição. Foram utilizados modelos lineares generalizados de regressão de Poisson, controlando-se para sazonalidade de longa duração, dias da semana e feriados. A seguir foi calculado o aumento no número de internações para a diferença interquartil dos poluentes significativos no modelo de regressão, bem como para os fatores meteorológicos. Para todas as admissões hospitalares por Doenças Cardiovasculares Totais, foram observados efeitos agudos de curta duração. O O3 foi o único poluente que não teve relação a nenhum dos desfechos analisados e o NO2 foi o que teve o efeito maior, para um aumento de interquartil 50,22 µg/m³ de NO2, revelou um aumento de 13,09% (IC95%: 4,74% - 21,45%), entre as internações totais de 30 a 44 anos. Estratificando a análise por faixa etária, encontrou-se um maior efeito para as internações de 45 a 60 anos. No que diz respeito ao sexo, entre a faixa etária 30 a 44, sobressaíram os homens, e para a faixa etária de 45 a 60 anos, as mulheres foram mais afetadas que os homens.